Rubalcava-Gracia Diana, Vázquez-Acevedo Miriam, Funes Soledad, Pérez-Martínez Xochitl, González-Halphen Diego
Departamento de Genética Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 Ciudad México, D. F., Mexico.
Mol Biol Cell. 2018 Apr 1;29(7):820-833. doi: 10.1091/mbc.E17-09-0560.
Deletion of the yeast mitochondrial gene , encoding subunit 2 (mtCox2) of cytochrome oxidase (CO), results in a respiratory-incompetent strain. For a cytosol-synthesized Cox2 to restore respiratory growth, it must carry the W56R mutation (cCox2). Nevertheless, only a fraction of cCox2 is matured in mitochondria, allowing ∼60% steady-state accumulation of CO. This can be attributed either to the point mutation or to an inefficient biogenesis of cCox2. We generated a strain expressing the mutant protein mtCox2 inside mitochondria which should follow the canonical biogenesis of mitochondria-encoded Cox2. This strain exhibited growth rates, CO steady-state levels, and CO activity similar to those of the wild type; therefore, the efficiency of Cox2 biogenesis is the limiting step for successful allotopic expression. Upon coexpression of cCox2 and mtCox2, each protein assembled into CO independently from its genetic origin, resulting in a mixed population of CO with most complexes containing the mtCox2 version. Notably, the presence of the mtCox2 enhances cCox2 incorporation. We provide proof of principle that an allotopically expressed Cox2 may complement a phenotype due to a mutant mitochondrial gene. These results are relevant to developing a rational design of genes for allotopic expression intended to treat human mitochondrial diseases.
酵母线粒体基因的缺失,该基因编码细胞色素氧化酶(CO)的亚基2(mtCox2),会导致一个呼吸功能不全的菌株。对于一种胞质溶胶合成的Cox2要恢复呼吸生长,它必须携带W56R突变(cCox2)。然而,只有一小部分cCox2在线粒体中成熟,使得CO的稳态积累达到约60%。这要么可归因于点突变,要么可归因于cCox2的生物合成效率低下。我们构建了一个菌株,其在线粒体内表达突变蛋白mtCox2,该蛋白应遵循线粒体编码的Cox2的经典生物合成途径。该菌株表现出与野生型相似的生长速率、CO稳态水平和CO活性;因此,Cox2生物合成的效率是成功进行异位表达的限制步骤。当cCox2和mtCox2共表达时,每种蛋白都独立于其基因来源组装到CO中,导致CO形成混合群体,大多数复合物含有mtCox2版本。值得注意的是,mtCox2的存在增强了cCox2的掺入。我们提供了原理证明,即异位表达的Cox2可能由于突变的线粒体基因而补充一种表型。这些结果与开发用于治疗人类线粒体疾病的异位表达基因的合理设计相关。